+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment of adolescent ADHD with OROS methylphenidate



Treatment of adolescent ADHD with OROS methylphenidate



Pediatric Research 53(4 Part 2): 555A




(PDF emailed within 1 workday: $29.90)

Accession: 035980831

Download citation: RISBibTeXText


Related references

Treating nicotine dependence by targeting attention-deficit/ hyperactivity disorder (ADHD) with OROS methylphenidate: the role of baseline ADHD severity and treatment response. Journal of Clinical Psychiatry 74(10): 983-990, 2014

Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD. Annals of Clinical Psychiatry 22(2): 94-102, 2010

OROS formulation of methylphenidate in treatment for ADHD Duration of effect. Pediatric Research. 51(4 Part 2): 21a, Il, 2002

OROS formulation of methylphenidate in treatment for ADHD Duration of effect. Pediatric Research. 51(4 Part 2): 21a, Il, 2002

Optimizing methylphenidate delivery to improve treatment for ADHD Results with OROS. Pediatric Research 47(4 Part 2): 29A, 2000

Impact of ADHD treatment with a once-daily OROS formulation of methylphenidate on tics. Pediatric Research 53(4 Part 2): 555A-556A, 2003

Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD. Child Neuropsychology 20(3): 319-327, 2014

Impact of ADHD treatment with a once-daily OROS formulation of methylphenidate on tics. Pediatric Research 53(4 Part 2): 555A-556A, 2003

Comparison of the efficacy and safety of OROS methylphenidate HCl with methylphenidate tid and placebo in children with ADHD. Pediatric Research 47(4 Part 2): 34A, 2000

Comparison of the efficacy and safety of OROS methylphenidate HCl with methylphenidate tid and placebo in children with ADHD. Pediatric Research 47(4 Part 2): 34A, 2000

Neurocognitive effects of switching from methylphenidate-IR to OROS-methylphenidate in children with ADHD. Human Psychopharmacology 24(2): 95-102, 2009

The Effects of Transdermal Methylphenidate With Reference to OROS Methylphenidate in ADHD. Journal of Developmental & Behavioral Pediatrics 27(5): 441-442, 2006

Evaluation of efficacy and safety of OROS methylphenidate HCl extended-release tablets, methylphenidate tid, and placebo in children with ADHD. Pediatric Research 47(4 Part 2): 36A, 2000

A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate. Journal of Attention Disorders 15(4): 286-294, 2011

OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study. Annals of Clinical Psychiatry 22(3): 196-204, 2011